Redx Pharma | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Deals

7 February 2024

Jazz joins the KRAS band with Redx deal

Regulatory

4 December 2023

Lilly makes steady progress in non-covalent BTK inhibition

Jaypirca secures a CLL label, though plans to dominate will be tempered by this market’s fast-changing nature.

Subscribe to Redx Pharma